Analyst Ranking
Bottom 11%
#4427 out of 4955 analysts
Average Return
-9.51%
Win Rate
25%4 out of 16
Risk vs Reward
Poor
Good

Yale Jen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+463.67%$11.81$66.57
2024-07-29 -
2025-07-28
Strong Buy
Nls Pharmaceutics LtdNLSP
+80.00%$24.00$43.20
2022-09-06 -
2023-09-05
Strong Buy
Evofem Biosciences IncEVFM
+38.95%$0.34$0.48
2022-06-02 -
2022-08-10
Strong Buy
Soleno Therapeutics IncSLNO
+27.62%$67.39$86.00
2025-03-27 -
2025-08-01
Strong Buy

Yale Jen Analyst Color

Get additional color on Yale Jen's coverage of popular stocks

Yale Jen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Senti Biosciences IncSNTI
1Strong Buy$5.00+197.62%Initiates Coverage On
2 months ago
Soleno Therapeutics IncSLNO
1Strong Buy$105.00+22.09%Maintains
4 months ago
Nuvectis Pharma IncNVCT
1Strong Buy$19.00+179.41%Initiates Coverage On
5 months ago
Lifeward LtdLFWD
1Strong Buy$10.00+1,336.78%Initiates Coverage On
6 months ago
Abivax SaABVX
1Strong Buy$48.00N/AInitiates Coverage On
a year ago
Affimed NvAFMDQ
1Strong Buy$25.00N/AMaintains
a year ago
Biomx IncPHGE
1Strong Buy$25.00N/AInitiates Coverage On
a year ago
In8bio IncINAB
1Strong Buy$225.00N/AInitiates Coverage On
a year ago
Silo Pharma IncSILO
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Bellerophon Therapeutics IncBLPH
1Strong Buy$35.00N/AInitiates Coverage On
2 years ago
Nls Pharmaceutics LtdNLSP
1Strong Buy$240.00N/AInitiates Coverage On
3 years ago
Evofem Biosciences IncEVFM
1Strong Buy$3.50N/AInitiates Coverage On
3 years ago
Cingulate IncCING
1Strong Buy$2,040.00N/AInitiates Coverage On
4 years ago
Vincerx Pharma IncVINC
1Strong Buy$600.00N/AInitiates Coverage On
4 years ago
F Star Therapeutics IncFSTX
1Strong Buy$32.00N/AInitiates Coverage On
4 years ago
Athenex IncATNXQ
1Strong Buy$720.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.